SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-004709
Filing Date
2020-01-09
Accepted
2020-01-09 16:20:09
Documents
13
Period of Report
2020-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d827188d8k.htm   iXBRL 8-K 27815
2 EX-99.1 d827188dex991.htm EX-99.1 21288
  Complete submission text file 0001193125-20-004709.txt   175857

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ptla-20200109.xsd EX-101.SCH 3067
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptla-20200109_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptla-20200109_pre.xml EX-101.PRE 10951
8 EXTRACTED XBRL INSTANCE DOCUMENT d827188d8k_htm.xml XML 3270
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35935 | Film No.: 20518391
SIC: 2834 Pharmaceutical Preparations